RBC Capital Reiterates Outperform Rating on Ionis Pharmaceuticals (IONS)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| (NASDAQ: IONS) | Delayed: 40.15 -0.27 (0.67%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $40.42 | 52 Week High | $62.68 | |||
| Open | $41.38 | 52 Week Low | $19.59 | |||
| Day High | $41.53 | P/E | N/A | |||
| Day Low | $39.33 | EPS | $0.00 | |||
| Volume | 4,102,756 | |||||
